Clinical Trials Directory

Trials / Conditions / Myotonic Dystrophy Type 1

Myotonic Dystrophy Type 1

17 registered clinical trials studyying Myotonic Dystrophy Type 1 — 8 currently recruiting.

StatusTrialSponsorPhase
Enrolling By InvitationGlobal Open-Label Extension Study of Del-desiran for the Treatment of DM1
NCT07008469
Avidity Biosciences, Inc.Phase 3
Active Not RecruitingFall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1
NCT07493525
Antalya Training and Research Hospital—
RecruitingThe Spanish National Registry for Myotonic Dystrophy Type 1
NCT07385443
Fundació Institut Germans Trias i Pujol—
RecruitingMusic Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)
NCT06809049
Hanns LochmullerN/A
Not Yet RecruitingWheelchair Skills Training for People with ARSACS and DM1
NCT06596850
Laval UniversityN/A
RecruitingPelvic Floor Muscle Training for Women with Myotonic Dystrophy
NCT06316778
Université de SherbrookeN/A
UnknownVirtual Reality-training in Theory of Mind in the Childhood Form of Myotonic Dystrophy Type 1
NCT05916677
Institut de Myologie, FranceN/A
RecruitingBrain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
NCT05854433
Wake Forest University Health Sciences—
RecruitingCerebrospinal Fluid Biomarkers of Myotonic Dystrophy
NCT06075693
Massachusetts General Hospital—
TerminatedAssessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
NCT03867435
National Institute of Neurological Disorders and Stroke (NINDS)—
CompletedPhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)
NCT02831504
Newcastle-upon-Tyne Hospitals NHS Trust—
CompletedA Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
NCT02312011
Ionis Pharmaceuticals, Inc.Phase 1 / Phase 2
CompletedObservational Prolonged Trial in Myotonic Dystrophy Type 1
NCT02118779
Radboud University Medical CenterN/A
UnknownChildren's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myoto
NCT02269865
Stanford University—
CompletedMulticenter Observational Study of Myotonic Dystrophy Type 1
NCT02308657
University of Rochester—
CompletedSafety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Gro
NCT00577577
Insmed IncorporatedPhase 2
RecruitingMyotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
NCT00082108
University of Rochester—